WHO Public Assessment Reports (WHOPARs) published
M
Cadila’s dispersible isoniazid tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Cadila’s dispersible ethambutol tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list :
First dispersible rifapentine tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Active Pharmaceutical Ingredient (API) Prequalified
M
Lamivudine (WHOAPI-428) manufactured by Styrax Life Sciences Pvt Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
Public announcement to TB in vitro diagnostics manufacturers, procurement agencies and national TB programmes: Extension of WHO GTB recommendation-based procurement eligibility for TB NAT assays until 31 December 2025
IVD
The World Health Organization (WHO), through its Prequalification Unit and Global Tuberculosis Programme, would like to announce that the transition period for WHO procurement el
Active Pharmaceutical Ingredient (API) Prequalified
M
Rifampicin (WHOAPI-507) manufactured by Macleods Pharmaceuticals Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
22nd Invitation to Manufacturers and Suppliers of Medicinal Products for HIV Infections and Related Diseases to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
M
The Invitation to Manufacturers for HIV Infections and Related Diseases to submit an Expression of Interest for Product E
Macleods’ bedaquiline tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: